$ARX hot sector hot chart. Nice reaction to morning selling.The best fat stocks bounce in all the right places. Great reaction off the 8 day today... #skuncat
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.020 AUD
−9.85 M AUD
64.02 M AUD
227.43 M
About AROA BIOSURGERY LIMITED
Sector
Industry
CEO
Brian Roderick Ward
Website
Headquarters
Mangere
Founded
2008
ISIN
NZARXE0001S1
FIGI
BBG00VX929P6
Aroa Biosurgery Ltd. engages in the development, manufacturing, and marketing of soft tissue repair products. It focuses on healing for complex wounds, and soft tissue reconstruction procedures including abdominal wall reconstruction, breast reconstruction, and reconstructive surgery for trauma, limb salvage, and tumor resections. The company was founded by Brian Roderick Ward in 2008 and is headquartered in Mangere, New Zealand.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ARX is 0.680 AUD — it has decreased by −2.16% in the past 24 hours. Watch AROA BIOSURGERY LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange AROA BIOSURGERY LIMITED stocks are traded under the ticker ARX.
ARX stock has risen by 4.62% compared to the previous week, the month change is a 5.43% rise, over the last year AROA BIOSURGERY LIMITED has showed a −6.85% decrease.
We've gathered analysts' opinions on AROA BIOSURGERY LIMITED future price: according to them, ARX price has a max estimate of 1.06 AUD and a min estimate of 0.76 AUD. Watch ARX chart and read a more detailed AROA BIOSURGERY LIMITED stock forecast: see what analysts think of AROA BIOSURGERY LIMITED and suggest that you do with its stocks.
ARX stock is 4.51% volatile and has beta coefficient of −0.15. Track AROA BIOSURGERY LIMITED stock price on the chart and check out the list of the most volatile stocks — is AROA BIOSURGERY LIMITED there?
Today AROA BIOSURGERY LIMITED has the market capitalization of 234.53 M, it has decreased by −0.76% over the last week.
Yes, you can track AROA BIOSURGERY LIMITED financials in yearly and quarterly reports right on TradingView.
AROA BIOSURGERY LIMITED is going to release the next earnings report on May 20, 2025. Keep track of upcoming events with our Earnings Calendar.
ARX earnings for the last half-year are −0.01 AUD per share, whereas the estimation was −0.01 AUD, resulting in a −37.14% surprise. The estimated earnings for the next half-year are 0.00 AUD per share. See more details about AROA BIOSURGERY LIMITED earnings.
AROA BIOSURGERY LIMITED revenue for the last half-year amounts to 39.46 M AUD, despite the estimated figure of 35.88 M AUD. In the next half-year revenue is expected to reach 42.06 M AUD.
ARX net income for the last half-year is −3.01 M AUD, while the previous report showed −4.02 M AUD of net income which accounts for 24.95% change. Track more AROA BIOSURGERY LIMITED financial stats to get the full picture.
No, ARX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AROA BIOSURGERY LIMITED EBITDA is −5.98 M AUD, and current EBITDA margin is −11.50%. See more stats in AROA BIOSURGERY LIMITED financial statements.
Like other stocks, ARX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AROA BIOSURGERY LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AROA BIOSURGERY LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AROA BIOSURGERY LIMITED stock shows the sell signal. See more of AROA BIOSURGERY LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.